Cms-10434 #26 Aqm2017-saa

Centers for Medicare & Medicaid Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
AQM 2017 - Adherence to Antipsychotics for
Individuals with Schizophrenia (SAA) Core
Measure PRA document
Version 1.0
08/29/2017

Document Number: 289-QSSI-MACPro-PRA-AQM2017-SAA-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents

Table of Contents
1. Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core
Measure – Screenshots ........................................................................................... 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7

Are you reporting on this measure? ................................................................ 1
Measurement Specification – Path 1 ............................................................... 1
Measurement Specification – Path 2 ............................................................... 1
Data Source .................................................................................................... 2
Performance Measure ..................................................................................... 2
Deviations from Measurement Specifications ................................................. 2
Optional Measure Stratification ....................................................................... 3

Appendix A:

Acronyms ......................................................................................... 4

List of Figures
Figure 1: Are you reporting on this measure ................................................................... 1
Figure 2: Measurement Specification – 1 ........................................................................ 1
Figure 3: Measurement Specification – 2 ........................................................................ 1
Figure 4: Data Source ..................................................................................................... 2
Figure 5: Performance Measure ...................................................................................... 2
Figure 6: Deviations from Measurement Specifications .................................................. 2
Figure 7: Optional Measure Stratification – 1 .................................................................. 3
Figure 8: Optional Measure Stratification – 2 .................................................................. 3

List of Tables
Table 1: Acronyms .......................................................................................................... 4

AQM 2017 - Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure PRA document
Version 1.0
i

08/29/2017

CMS XLC

Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure – Screenshots

1. Adherence to Antipsychotics for Individuals with
Schizophrenia (SAA) Core Measure – Screenshots
1.1

Are you reporting on this measure?

Figure 1: Are you reporting on this measure?

1.2

Measurement Specification – Path 1

Figure 2: Measurement Specification – 1

1.3

Measurement Specification – Path 2

Figure 3: Measurement Specification – 2

AQM 2017 - Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure PRA document
Version 1.0
1

08/29/2017

CMS XLC

1.4

Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure – Screenshots

Data Source

Figure 4: Data Source

1.5

Performance Measure

Figure 5: Performance Measure

1.6

Deviations from Measurement Specifications

Figure 6: Deviations from Measurement Specifications

AQM 2017 - Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure PRA document
Version 1.0
2

08/29/2017

CMS XLC

1.7

Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure – Screenshots

Optional Measure Stratification

Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 7: Optional Measure Stratification – 1

Figure 8: Optional Measure Stratification – 2

AQM 2017 - Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure PRA document
Version 1.0
3

08/29/2017

CMS XLC

Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure – Screenshots

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Literal Translation

AQM

Adult Quality Measure

PRA

Paper Reduction Act of 1995

AQM 2017 - Adherence to Antipsychotics for Individuals with Schizophrenia (SAA) Core Measure PRA document
Version 1.0
4

08/29/2017